Sub1p1: A Promising Biomarker for Pregnancy and Cancer (G728938)

Target Name: SUB1P1

NCBI ID: G728938

SUB1P1

Other Name(s): hCG17750 | SUB1 pseudogene 1

Sub1p1: A Promising Biomarker for Pregnancy and Cancer

Sub1p1 (hCG17750) is a human chorionic gonadotropin (hCG) antibody that is derived from a single celled pregnancy tissue. It is expressed in the urine and blood of pregnant women and has been used as a marker for pregnancy, fetal development, and certain types of cancer.

hCG is a protein that is produced by the placenta after fertilization occurs. It is a key component of the placenta and helps to support the growth and development of the fetus. Once hCG is produced, it is carried in the urine and blood of the pregnant woman, and it can be used as a marker for pregnancy.

Sub1p1 is a specific type of hCG antibody that is derived from the placenta of pregnant women. It is produced by a single celled clone of the placenta and is expressed in the urine and blood of pregnant women. The sub1p1 antibody has been shown to be sensitive to hCG levels that are less than 100 ng/mL, which makes it a useful biomarker for detecting low-hCG pregnancy.

In addition to its use as a pregnancy marker, sub1p1 has also been shown to have potential as a drug target. One potential mechanism by which sub1p1 may work as a drug target is by interacting with the hCG receptor, which is a protein that is expressed in the placenta and other tissues. The hCG receptor is involved in the signaling process that regulates fetal growth and development, and sub1p1 has been shown to block the activity of the hCG receptor, which could potentially inhibit the growth and development of cancer cells.

Another potential mechanism by which sub1p1 may work as a drug target is by activating the immune system. Pregnant women who have high levels of sub1p1 may be more likely to develop an immune response to the placenta, which could potentially lead to an immune-mediated pregnancy complications. This could be an attractive target for a drug that is designed to prevent pregnancy complications.

In conclusion, sub1p1 is a promising biomarker for pregnancy and a potential drug target. Further research is needed to fully understand its potential applications in both pregnancy and cancer.

Protein Name: SUB1 Pseudogene 1

The "SUB1P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SUB1P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets